Products | News | Manufacturers Home Home | Register | Login | Post Buying Requests | Display Products
Path : Home > Products > Veterinary Medicine > Pet Medications > Pet Medications



Products > Pet Medications >

ONCOVET C (Cyclophosphamide)

- 20-125
Total 2 Related Items Showing 1     Previous   Next
ONCOVET C (Cyclophosphamide)
Click for Larger Photo
ONCOVET C (Cyclophosphamide)
Product Details:
Model Number:20-125
Brand Name:ONCOVET C
Payment & Shipping Terms:
Minimum Order Quantity:1000 Box/Boxes
Packaging Details:Cychophosphamide 50 mg - Tablets. Package: 3 blister containing 10 pills each (30 tablets).
Price Terms:USD 1~1 Buenos Aires
Payment Terms:T/T, PayPal, Western Union
Supply Abiity: per Time

ONCOVET C (Cyclophosphamide) Product Description


Cyclophosphamide 50 mg - Tablets


Description: Chemotherapy for dogs and cats. Composition: Cyclophosphamide: 50 mg  Excipients authorized. 166 mg c.s.p.


Action: Chemotherapy. The basic idea behind drugs of cancer chemotherapy is for them to reach areas of the body that are inaccessible to surgery and to kill only the cancer cells and leave alone the normal cells of the body. Cyclophosphamide is a member of the alkylating agent of chemotherapy, which act by binding DNA to other DNA strands or to protein in such a way that the DNA double helix strand cannot replicate. In addition to essentially tangling DNA up, cyclophosphamide generates a by-product that prevents normal DNA function.  


Indications: Canine treatment with cancer (carcinomas of anal sacs, bladder carcinomas, urethral carcinomas, hemangiosarcomas, lymphomas, mast cell tumor, osteosarcomas, soft tissue sarcoma), feline cancers (mammary carcinomas, hemangiosarcomas, lymphomas, plasmacytomas, chronic lymphocytic leukemia, leukemia acute myelogenous, mast cell tumor), immunomediated canine diseases (immune-mediated hemolytic anemia, immune-mediated arthritis, immune-mediated glomerulonephritis, immune-mediated meningoencephalitis, immune-mediated pemphigus and thrombocytopenia) and feline immunomediated diseases (immune-mediated hemolytic anemia and immune-mediated arthritis). It can be administered in different treatment schemes, such as induction therapy, adjuvant, neoadjuvant, maintenance and metronomic chemotherapy. 


Go to Top

HOME - About - Industry Links - Advertise - Contact

Copyright 2001-2029 All right reserved